MDSL
CHE icon

M.D. Sass LLC’s Chemed CHE Stock Holding History

M.D. Sass LLC’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-51,108
Closed -$32.8M – 34
2024
Q1 		$32.8M Sell
51,108
-5,905
-10% -$3.59M 3.7% 12
2023
Q4 		$33.3M Sell
57,013
-10,252
-15% -$5.74M 4.01% 12
2023
Q3 		$35M Buy
67,265
+8,999
+15% +$4.68M 4.7% 7
2023
Q2 		$31.6M Buy
58,266
+1,514
+3% +$828K 4.19% 10
2023
Q1 		$30.5M Sell
56,752
-4,644
-8% -$2.37M 3.8% 9
2022
Q4 		$31.3M Buy
61,396
+2,554
+4% +$1.24M 4.61% 8
2022
Q3 		$25.7M Buy
58,842
+3,304
+6% +$1.59M 4.71% 10
2022
Q2 		$26.1M Buy
55,538
+14,501
+35% +$7.07M 4.93% 12
2022
Q1 		$20.8M Buy
41,037
+11,627
+40% +$5.58M 3.56% 16
2021
Q4 		$15.6M Buy
+29,410
New +$14.1M 2.42% 20

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

M.D. Sass LLC's CHE Position: Q2 2024 in Review

M.D. Sass LLC sold out of Chemed (CHE) in Q2 2024, closing a stake of 51,108 shares — an estimated $32.8M sold.

M.D. Sass LLC first reported a position in CHE in Q4 2021 and held it in 10 quarters. The position peaked at $35M in Q3 2023. 513 funds tracked by Wall St. Rank hold CHE as of Q2 2024.

  • M.D. Sass LLC reported no remaining Chemed position as of Q2 2024 after selling out during the quarter.
  • M.D. Sass LLC sold 51,108 Chemed shares in Q2 2024, an estimated $32.8M.
  • M.D. Sass LLC first reported a position in Chemed in Q4 2021 and held it in 10 quarters.
  • M.D. Sass LLC's Chemed position peaked at $35M in Q3 2023.
  • 513 funds tracked by Wall St. Rank held Chemed as of Q2 2024.

Based on M.D. Sass LLC's 13F filing for Q2 2024, filed 13 Aug 2024.